Claudia Pigliacelli

Dr. Claudia Pigliacelli


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2014 in Chemical Reviews
Verified
Journal Article
Closed access
ITIlaria Tirotta
Ilaria Tirotta
VDValentina Dichiarante
Valentina Dichiarante
CPClaudia Pigliacelli
Claudia Pigliacelli
GCGabriella Cavallo
Gabriella Cavallo
GTGiancarlo Terraneo
Giancarlo Terraneo
Giuseppe ResnatiGiuseppe Resnati
Giuseppe Resnati

15 September 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
SQSheng Qi
Sheng Qi
SRSteve Roser
Steve Roser
KEKaren Edler
Karen Edler
CPClaudia Pigliacelli
Claudia Pigliacelli
MRMadeleine Rogerson
Madeleine Rogerson
SSSigrid Stokbroekx
Sigrid Stokbroekx

4 June 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CPClaudia Pigliacelli
Claudia Pigliacelli
RSRosalía Sánchez-Fernández
Rosalía Sánchez-Fernández
MGMarcos D. García
Marcos D. García
CPCarlos Peinador
Carlos Peinador
EPElena Pazos
Elena Pazos
Self-assembled peptide–nanoparticle superstructures, with tuned architectures and/or functionalities, hold great promise in multiple high-end applications.

17 August 2017 in ACS Nano
Verified
Journal Article
Open access
DMDaniele Maiolo
Daniele Maiolo
CPClaudia Pigliacelli
Claudia Pigliacelli
PMPAOLA SANCHEZ MORENO
PAOLA SANCHEZ MORENO
MVMartina Bruna Violatto
Martina Bruna Violatto
LTLaura Talamini
Laura Talamini
FBFrancesca Baldelli Bombelli
Francesca Baldelli Bombelli
One of the main hurdles in nanomedicine is the low stability of drug–nanocarrier complexes as well as the drug delivery efficiency in the region-of-interest. Here, we describe the use of the film-forming protein hydrophobin HFBII to organize dodecanethiol-protected gold nanoparticles (NPs) into well-defined supraparticles (SPs). The obtained SPs are exceptionally stable in vivo and efficiently encapsulate hydrophobic drug molecules. The HFBII film prevents massive release of the encapsulated drug, which, instead, is activated by selective SP disassembly triggered intracellularly by glutathione reduction of the protein film. As a consequence, the therapeutic efficiency of an encapsulated anticancer drug is highly enhanced (2 orders of magnitude decrease in IC50). Biodistribution and pharmacokinetics studies demonstrate the high stability of the loaded SPs in the bloodstream and the selective release of the payloads once taken up in the tissues. Overall, our results provide a rationale for the development of bioreducible and multifunctional nanomedicines.

1 May 2020 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
APAndrea Pizzi
Andrea Pizzi
CPClaudia Pigliacelli
Claudia Pigliacelli
GBGreta Bergamaschi
Greta Bergamaschi
AGAlessandro Gori
Alessandro Gori
PMPierangelo Metrangolo
Pierangelo Metrangolo

22 June 2017 in Nanoscale
Verified
Journal Article
Open access
PDF file
APAndrea Pizzi
Andrea Pizzi
CPClaudia Pigliacelli
Claudia Pigliacelli
AGAlessandro Gori
Alessandro Gori
Nonappa ..Nonappa ..
Nonappa ..
OIOlli Ikkala
Olli Ikkala
PMPierangelo Metrangolo
Pierangelo Metrangolo
Upon changing the position, nature and number of the halogen atoms, the same amyloidogenic peptide self-assembles into different nanostructures.